FEATURE INVESTIGATIONIn development
Have Value-Based Care Intermediaries Created Shareholder Wealth?
The economics of the additional management, technology, and analytics layer between payers and providers.
Evidence and methodsExamine matched-period shareholder returns, operating results, dilution, capital consumption, and competitive performance among publicly traded intermediaries.
Research objectiveDetermine whether the intermediary business model has delivered attractive returns to investors, and identify differences among companies.
The investigation is in development. No company-level conclusions or performance figures are published here.
SECTOR INVESTIGATIONPlanned
Why Do Pharmaceutical Companies Produce Such Different Investor Returns?
Market opportunity, product economics, and the wide dispersion of investor outcomes.
Evidence and methodsStudy five-year total returns alongside addressable markets, product concentration, development costs, patent protection, manufacturing scale, and capital allocation.
Research objectiveExplore whether particular operating and financial characteristics help explain the difference between exceptional and disappointing returns.
Hypotheses are under examination; proposed explanatory factors are not established causal findings.
COMPARATIVE ANALYSISPlanned
Hospital Operators: Similar Industry, Divergent Returns
Why companies facing similar reimbursement and labor pressures can produce very different investor outcomes.
Evidence and methodsCompare operating cash flow, leverage, capital expenditures, acquisitions, equity dilution, and matched-period shareholder returns.
Research objectiveDistinguish the contributions of operating execution, financial structure, and capital allocation.
Company comparisons will be published only after financial and return data have been reconciled.
INDUSTRY-WIDE PROGRAMIn development
The Health Care Value Creation Framework: Industry-Wide Analysis
A systematic comparison of shareholder wealth creation across health care sectors and subsectors.
Evidence and methodsBuild a reconciled company universe, include surviving and delisted companies where data permit, and compare total shareholder returns with the S&P 500 and Russell 3000 over matching periods.
Research objectiveIdentify historical patterns that may inform a future, prospectively tested investment evaluation framework.
The prospective framework is a research objective, not a validated predictive investment model.